Cite

HARVARD Citation

    d'Apolito, M. et al. (2022). Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report. Therapeutic advances in chronic disease. p. . [Online]. 
  
Back to record